Synthesis of selenium-75 labeled tertiary diamines: new brain imaging agents.
Selenium-75 labeled tertiary diamines, bis[beta-(N,N-dimethylamino )ethyl] selenide (1), bis[beta-(N,N-diisopropylamino)ethyl] selenide (2), bis(beta-piperidinoethyl) selenide (3), and bis(beta-morpholinoethyl) selenide (4), were prepared by reducing [75Se]selenious acid with sodium borohydride and reacting the intermediate with the N,N-disubstituted aminoethyl chlorides. The effect of pH on lipid solubility (1-octanol/buffer distribution coefficient) was measured for each labeled compound. Biodistribution studies in rats showed high brain uptake for the tertiary diamines, especially for 3 and 4 (1.53 and 1.49% dose/organ, respectively, at 30 min after iv injection). The permanently charged bisquaternary amine, bis[beta-(N,N,N-trimethylammonio)ethyl] selenide (5), showed negligible brain uptake (0.06% dose/organ at 30 min).
D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging*; D003959:Diamines / Q000138:chemical synthesis / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007553:Isotope Labeling; D008297:Male; D011868:Radioisotopes; D011877:Radionuclide Imaging; D051381:Rats; D012643:Selenium; D012995:Solubility; D014018:Tissue Distribution
D003959:Diamines; D011868:Radioisotopes; D012643:Selenium